Swara Baby Products gets SEBI observations for Rs 1,000 crore IPO

The Development

Swara Baby Products Limited, a Madhya Pradesh-based contract manufacturer of disposable hygiene products, has received the Securities and Exchange Board of India's observations on its draft red herring prospectus, clearing the company to proceed with a proposed initial public offering of up to Rs 1,000 crore, according to a report in The Economic Times. The development marks the regulator's processing of the draft offer document the company filed earlier in the year.

Per the draft red herring prospectus, dated July 2, 2026 and available on SEBI's website, the offer comprises a fresh issue of equity shares aggregating up to Rs 5,000.00 million (about Rs 500 crore) and an offer for sale of up to Rs 5,000.00 million (about Rs 500 crore) by two promoter selling shareholders, taking the total offer to up to Rs 10,000.00 million (about Rs 1,000 crore). The shares carry a face value of Rs 2 each and are proposed to be listed on the BSE and the NSE.

SEBI's observations are clearance to proceed, not an endorsement of the issue. The DRHP itself records that the equity shares have "neither been recommended nor approved" by the regulator, which does not guarantee the accuracy of the document.

The Company

Swara Baby Products describes itself as a specialised, independent manufacturer of disposable consumer hygiene products across the baby care, adult incontinence and feminine hygiene categories. The company contract manufactures baby and adult pant and tape style diapers, sanitary napkins and panty liners for other brands, and also makes and sells its own home-brand diapers direct to consumers. Per the DRHP, citing a TKC Report, it was the largest contract manufacturer of baby diapers in India by revenue in Fiscal 2025, with a 37% market share by value, and the largest adult diaper contract manufacturer, with an estimated 36% share. The company discloses that it operates four manufacturing facilities with 20 manufacturing lines in Pithampur and Indore, Madhya Pradesh, as of March 31, 2026.

The company discloses restated consolidated revenue from operations of Rs 11,639.00 million (about Rs 1,164 crore) for Fiscal 2026, up from Rs 9,429.76 million in Fiscal 2025 and Rs 7,499.60 million in Fiscal 2024. Profit for the year was Rs 955.89 million (about Rs 96 crore) in Fiscal 2026, against Rs 806.73 million in Fiscal 2025 and Rs 939.71 million in Fiscal 2024, per the DRHP. The offer document states EBITDA of Rs 1,927.70 million and net worth of Rs 5,532.15 million for Fiscal 2026.

The Offer Structure

The fresh issue is capped at Rs 5,000.00 million and the offer for sale at Rs 5,000.00 million, the latter split between promoter selling shareholders Brainbees Solutions Limited, offering up to Rs 3,000.00 million, and Anadya Bon Merchari LLP, offering up to Rs 2,000.00 million, per the DRHP. Brainbees Solutions, the operator of the FirstCry and Babyhug brands, is both a promoter and the company's single largest customer. The price band, lot size, minimum application amount and issue dates are not yet set; they appear as placeholders in the draft and are fixed at the red herring prospectus stage. The document also flags a possible pre-IPO placement of up to Rs 1,000.00 million.

The company proposes to use the net proceeds of the fresh issue towards part-financing capital expenditure of Rs 1,982.06 million for a new manufacturing facility at Pithampur, Rs 1,000.00 million for repaying borrowings, and Rs 275.00 million for investment in subsidiaries to repay their debt, with the balance for inorganic growth and general corporate purposes. JM Financial and Avendus Capital are the book-running lead managers, and MUFG Intime India is the registrar. Readers working through the arithmetic of a potential allotment can use Oquilia's lumpsum calculator or CAGR calculator, and the /news desk carries prior market coverage.

Risk Factors

The DRHP sets out the risks the company is required to disclose. It lists geographic concentration first: all four manufacturing facilities are located in Madhya Pradesh, which exposes the business to regional risks. The company also discloses heavy customer concentration, with the top ten customers accounting for 80.31% of revenue from operations in Fiscal 2026, and one corporate promoter, Brainbees Solutions, as the single largest customer; it notes that its customer arrangements do not obligate them to place orders.

Among the other risk factors the company discloses, supplier concentration features prominently, with the top ten suppliers making up 69.43% of raw material, traded goods and packing material purchases in Fiscal 2026, alongside exposure to raw-material prices and availability. The draft also flags product concentration, with baby diapers contributing 78.34% of revenue from operations in Fiscal 2026, and import dependence, as the company sources certain key raw materials from the United States and China and some manufacturing equipment from China.

What Happens Next

With SEBI's observations in hand, the standard sequence from here runs through the filing of the red herring prospectus with the Registrar of Companies, at which point the price band, lot size and the three-day bid/offer window are fixed and announced. An anchor investor allocation is typically finalised one working day before the issue opens, per the mechanics set out in the draft.

After the subscription window closes, the basis of allotment is finalised with the registrar and the exchanges, refunds and the unblocking of application money follow for unsuccessful or partially successful applicants, and the shares are then listed on the BSE and the NSE. The DRHP does not yet state these dates; they will appear in the red herring prospectus once filed. None of this sequence is a prediction of demand or price.

FAQ

Should I apply for this IPO?

Oquilia does not make recommendations. This report is informational and is not investment advice or a recommendation to subscribe. The RHP, including the complete risk-factors section, is available on SEBI's website and the exchanges - read it directly before making any decision.

What do SEBI's observations mean?

SEBI's observations are clearance for the company to proceed with the offer, not an endorsement or a view on its merits. The draft prospectus itself records that the equity shares have neither been recommended nor approved by SEBI, and that the regulator does not guarantee the accuracy of the document.

What is the issue size?

Per the DRHP, the total offer is up to Rs 10,000.00 million (about Rs 1,000 crore), made up of a fresh issue of up to Rs 5,000.00 million and an offer for sale of up to Rs 5,000.00 million by promoter selling shareholders Brainbees Solutions Limited and Anadya Bon Merchari LLP.

What is the price band and lot size?

These have not been announced. The draft red herring prospectus carries placeholders for the price band, lot size and minimum application amount. The company, in consultation with its lead managers, fixes them at the red herring prospectus stage, when the issue dates are also set.

Where can I read the RHP?

The draft red herring prospectus is on SEBI's website, and the final red herring prospectus, once filed, will be available there and on the BSE and NSE websites. The lead managers, JM Financial and Avendus Capital, also host the offer documents.

This report is based on the draft red herring prospectus filed with SEBI. It was surfaced via coverage in The Economic Times.